GlaxoSmithKline, Alector enter into collaboration valued at up to $2.2B

The collaboration focuses on two new drug candidates under development for multiple neurodegenerative diseases including ALS and Alzheimer's and Parkinson's diseases.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 2, 2021 Category: Pharmaceuticals Authors: John George Source Type: news